Hallucinogenic affect

An example of a hallucinogen affecting mammalian herbivores is the isox-azole muscimol (fig. 11.13), a mushroom toxin. It is a y-aminobutyric acid agonist in the central nervous system of vertebrates. Muscimol s role in nature... 

Toxins bufotenin, bufotenidin, bufoviridin, bufo-talin, bufotoxin, bufinin found in skin glands of Bufo vulgari common toad and related species. All hallucinogens affect Na/K ATPase. 

When looking for plants affecting serotoninergic neurotransmission, one might look into species that produce indole alkaloids, such alkaloids beingknown to impart to the plant s hallucinogenic properties. 

The data discussed in this section suggest that hallucinogens act in a complex manner to affect spinal reflexes. In general, the following conclusions may be justified ... 

Tonge, S. R., and Leonard, B. E. (1972) Some observations on the behavioral effects of hallucinogenic drugs on rats Potentiation by two drugs affecting monoamine metabolism. Arch. Int. Pharmacodyn., 195 168-176. 

Our goal in this discussion is to present the types of structural variations that have been studied in the various classes of hallucinogens and to explain how these changes affect biologic activity. Where possible, reasonable explanations for these differences are offered. Since we are just beginning to scratch the surface in our search for useful structure-activity relationships, the reader will soon note that most of the correlations are empirical, with no readily apparent biochemical or pharmacologic rationale. 

As mentioned herein, other neurotransmitters are affected by hallucinogens. Accordingly, the opposite changes in 5-HT and DA neurotransmission produced by these drugs seem necessary but insufficient to evoke hallucinations. Current studies on the effects of hallucinogens on recently detected neuroactive com-... 

Limb flicks in cats, production by hallucinogens of, 61-63 receptor systems that mediate, 62-63 Limb jerks, in primates, production by hallucinogens of, 63-64 Lisuride, behavioral affects of, 54-55 Locomotor behavior, effects of hallucinogens on, 49-51... 

While the majority of studies have focused on LSD, some evidence suggests that hallucinogens derived from the phenylethylamine nucleus affect locomotion in a manner that is interpretable only by considering the environmental context. For example, the substituted amphetamine DOM produces a dose-dependent (0.5-10 mg/kg) reduction in locomotor activity when rats are tested in a novel open field, while a slight but significant increase in activity is observed in a familiar environment (171). This report corroborates the separate findings of DOM-induced hyperactivity in rats or mice in a familiar chamber (29,196) and hypoactivity in mice in an unfamiliar setting (92). Mescaline (10 mg/kg) has also been reported to increase locomotion in rats in a familiar environment (196). 

A great deal of structural modification work has ensued in the subsequent years. At present, however, the level of effort and number of laboratories involved in this area are small compared to that during the 1960s and 1970s, when hallucinogens were a popular topic in the lay media. It will be easiest to describe this work by focusing on specific types of molecular modifications and how they affect activity. 

As discussed, PCP, ditran, and scopolamine exert anticholinergic action. This property apparently is not linked to the hallucinogenic action of these molecules, however, since other hallucinogens, such as LSD and mescaline, do not affect cholinergic systems in doses sufficient to provoke hallucinatory-like behaviors in animals (67). Nevertheless, Revuelta et al. (96) noted a decreased turnover... 

The possible effects of hallucinogens on central monoaminergic neurons were first explored by Freedman (34), who discovered that a single injection of LSD increases 5-HT levels in the rat brain, whereas its inactive congener BOL fails to affect brain 5-HT. Since this change is associated with a decrease in the concentration of the main metabolite of 5-HT, 5-hydroxyindole acetic acid (5-HIAA) (Fig. 1), Rosecrans et al. (98) postulated that LSD administration in... 

Saccades are also affected by anticholinergic hallucinogens in humans (Oliva et al. 1993). Increases in saccade duration and latency occur along with decreases in velocity. Postsaccadic fixation is impaired as well, where the eye drifts after reaching the target. 

The toxins affect the central nervous system (CNS). Symptoms start within twenty minutes and may last for two to four hours, but peak hallucinogenic activity rarely lasts for more than one hour. Symptoms include anxiety and tension, visual effects such as blurring, euphoria, increased color perception with closed eyes, but also headache and fatigue. The overall sensation is usually described as pleasant. 

The answer is E. Anesthetics are highly lipid-soluble and experiments with isolated membranes indicate that these molecules can dissolve in the hydrophobic center of the membrane bilayer. This causes a measurable increase in the membrane fluidity by disrupting the packed structure of phospholipids tails. This is considered to be the main, direct mechanism by which this class of drugs inhibits neurotransmission (pain sensations) in neurons. Hallucinogens and opiates may also affect membrane fluidity, but their effects occur by indirect mechanisms, resulting from changes in the protein or lipid composition of the membranes. 

BZ (QNB) Quinuclidinebenzillate, an incapacitating psychotomimetic agent developed in the 1950s. This psychochemical hallucinogen substance affects the nervous system, causing fake visual and aural perceptions and a sense of unreality. 

Salvinorin A is the first entheogenic diterpene reported and is active in humans at extraordinarily low doses. It does not appear to affect any of the receptor sites affected by other hallucinogens. Further research into the methods of action and possible medicinal values of this and similar compounds may prove to be quite rewarding. 

Sny drug affecting the mind or behavior is classified as psychoactive. In this section we focus on three classes of psychoacrive drugs stimulants, hallucinogens, and depressants. 

---